Methyl CpG binding protein 2 (MeCP2) enhances photodimer formation at methyl-CpG sites but suppresses dimer deamination

被引:7
|
作者
Cannistraro, Vincent J. [1 ]
Taylor, John-Stephen A. [1 ]
机构
[1] Washington Univ, Dept Chem, St Louis, MO 63130 USA
基金
美国国家卫生研究院;
关键词
CYCLOBUTANE PYRIMIDINE DIMERS; ACID-SOLUBLE PROTEINS; ALPHA/BETA-TYPE SMALL; DNA-POLYMERASE-ETA; UV PHOTOPRODUCTS; P53; MUTATIONS; IN-VIVO; HYDROLYTIC DEAMINATION; THYMINE DIMERIZATION; HISTONE DEACETYLASE;
D O I
10.1093/nar/gkq582
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Spontaneous deamination of cytosine to uracil in DNA is a ubiquitous source of C -> T mutations, but occurs with a half life of similar to 50 000 years. In contrast, cytosine within sunlight induced cyclobutane dipyrimidine dimers (CPD's), deaminate within hours to days. Methylation of C increases the frequency of CPD formation at PyCG sites which correlate with C -> T mutation hotspots in skin cancers. MeCP2 binds to (m)CG sites and acts as a transcriptional regulator and chromatin modifier affecting thousands of genes, but its effect on CPD formation and deamination is unknown. We report that the methyl CpG binding domain of MeCP2 (MBD) greatly enhances C=(m)C CPD formation at a TC(m)CG site in duplex DNA and binds with equal or better affinity to the CPD-containing duplex compared with the undamaged duplex. In comparison, MBD does not enhance T=(m)C CPD formation at a TT(m)CG site, but instead increases CPD formation at the adjacent TT site. MBD was also found to completely suppress deamination of the T=(m)CG CPD, suggesting that MeCP2 may have the capability to both suppress UV mutagenesis at Py(m)CpG sites as well as enhance it.
引用
收藏
页码:6943 / 6955
页数:13
相关论文
共 50 条
  • [41] The Methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation
    Fuks, F
    Hurd, PJ
    Wolf, D
    Nan, XS
    Bird, AP
    Kouzarides, T
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (06) : 4035 - 4040
  • [42] The methyl-CpG-binding protein MECP2 is required for prostate cancer cell growth
    D Bernard
    J Gil
    P Dumont
    S Rizzo
    D Monté
    B Quatannens
    D Hudson
    T Visakorpi
    F Fuks
    Y de Launoit
    [J]. Oncogene, 2006, 25 : 1358 - 1366
  • [43] CpG methylation and the methyl CpG binding protein 2 (MeCP2) are required for restraining corticotropin releasing hormone (CRH) gene expression
    Bhave, Shreyas A.
    Uht, Rosalie M.
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2017, 454 (0C) : 158 - 164
  • [44] Reduced methyl-CpG-binding protein 2 (MeCP2) in methyl deficient rat liver associated with altered expression of MeCP2 mRNA splice variants
    Esfandiari, F
    Cotterman, RF
    Green, R
    Miller, JW
    [J]. FASEB JOURNAL, 2003, 17 (04): : A672 - A672
  • [45] Early life stress exacerbates behavioural and neuronal alterations in adolescent male mice lacking methyl-CpG binding protein 2 (Mecp2)
    Torres-Perez, Jose Vicente
    Martinez-Rodriguez, Elena
    Forte, Anabel
    Blanco-Gomez, Carlos
    Stork, Oliver
    Lanuza, Enrique
    Santos, Monica
    Agustin-Pavon, Carmen
    [J]. FRONTIERS IN BEHAVIORAL NEUROSCIENCE, 2022, 16
  • [46] Investigation of the interaction between MeCP2 methyl-CpG binding domain and methylated DNA by single molecule force spectroscopy
    Qin, Juan
    Zhang, Miaomiao
    Guan, Yanxue
    Li, Chen
    Ma, Xingxing
    Rankl, Christian
    Tang, Jilin
    [J]. ANALYTICA CHIMICA ACTA, 2020, 1124 : 52 - 59
  • [47] Methyl-CpG-Binding Protein 2 (MECP2) Polymorphism in Iranian Patients with Systemic Lupus Erythematosus
    Alesaeidi, Samira
    Karami, Jafar
    Mahmoudi, Mahdi
    Akbarian, Mahmoud
    Poursani, Shiva
    Amirzadeh, Azadeh
    Haddadi, Nazgol-Sadat
    Saffari, Elahe
    Jamshidi, Ahmad Reza
    [J]. INFLAMMATION, 2015, 38 (06) : 2185 - 2190
  • [48] Methyl-CpG-Binding Protein 2 (MECP2) Polymorphism in Iranian Patients with Systemic Lupus Erythematosus
    Samira Alesaeidi
    Jafar Karami
    Mahdi Mahmoudi
    Mahmoud Akbarian
    Shiva Poursani
    Azadeh Amirzadeh
    Nazgol-Sadat Haddadi
    Elahe Saffari
    Ahmad Reza Jamshidi
    [J]. Inflammation, 2015, 38 : 2185 - 2190
  • [49] The Epigenetic Reader Methyl-CpG-Binding Protein 2 (MeCP2) Is an Emerging Oncogene in Cancer Biology
    Nejati-Koshki, Kazem
    Roberts, Chris-Tiann
    Babaei, Ghader
    Rastegar, Mojgan
    [J]. CANCERS, 2023, 15 (10)
  • [50] A WW domain binding region in methyl-CpG-binding protein MeCP2: impact on Rett syndrome
    Jan P. Buschdorf
    Wolf H. Strätling
    [J]. Journal of Molecular Medicine, 2004, 82 : 135 - 143